Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy
Rechallenge of Imatinib in GIST Having no Effective Treatment
Matching Patients With Hematologic Malignancy to Adequate Clinical Trials
Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
† Study has passed its completion date and status has not been verified in more than two years.